skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 92  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Public Health remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Automated identification of acute hepatitis B using electronic medical record data to facilitate public health surveillance
Material Type:
Article
Add to My Research

Automated identification of acute hepatitis B using electronic medical record data to facilitate public health surveillance

PloS one, 2008-07, Vol.3 (7), p.e2626-e2626 [Peer Reviewed Journal]

COPYRIGHT 2008 Public Library of Science ;2008 Klompas et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Klompas et al. 2008 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0002626 ;PMID: 18612462

Full text available

2
SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England
Material Type:
Article
Add to My Research

SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England

The Lancet Infectious Diseases, 2021-03, Vol.21 (3), p.344-353 [Peer Reviewed Journal]

2021 ;Crown Copyright © 2021 Published by Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Copyright Elsevier Limited Mar 2021 ;Crown Copyright © 2020 Published by Elsevier Ltd. All rights reserved. 2021 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30882-3 ;PMID: 33306981

Digital Resources/Online E-Resources

3
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study
Material Type:
Article
Add to My Research

Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study

The Lancet infectious diseases, 2018-04, Vol.18 (4), p.441-451 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 1, 2018 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(18)30052-5 ;PMID: 29395999

Full text available

4
Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study
Material Type:
Article
Add to My Research

Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study

The Lancet (British edition), 2016-12, Vol.388 (10061), p.2775-2782 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 3, 2016 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31921-3 ;PMID: 28100432 ;CODEN: LANCAO

Full text available

5
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study
Material Type:
Article
Add to My Research

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

BMJ (Online), 2021-05, Vol.373, p.n1088-n1088 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.n1088 ;PMID: 33985964

Full text available

6
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Material Type:
Article
Add to My Research

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

New England Journal of Medicine, 2021-08, Vol.385 (7), p.585-594 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2108891 ;PMID: 34289274

Digital Resources/Online E-Resources

7
Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England
Material Type:
Article
Add to My Research

Vaccination of Infants with Meningococcal Group B Vaccine (4CMenB) in England

The New England journal of medicine, 2020-01, Vol.382 (4), p.309-317 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1901229 ;PMID: 31971676

Full text available

8
Increase in Endemic Neisseria meningitidis Capsular Group W Sequence Type 11 Complex Associated With Severe Invasive Disease in England and Wales
Material Type:
Article
Add to My Research

Increase in Endemic Neisseria meningitidis Capsular Group W Sequence Type 11 Complex Associated With Severe Invasive Disease in England and Wales

Clinical infectious diseases, 2015-02, Vol.60 (4), p.578-585 [Peer Reviewed Journal]

Copyright © 2015 Oxford University Press on behalf of the Infectious Diseases Society of America ;The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com. ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciu881 ;PMID: 25389259

Full text available

9
Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UK
Material Type:
Article
Add to My Research

Summary of evidence to reduce the two-dose infant priming schedule to a single dose of the 13-valent pneumococcal conjugate vaccine in the national immunisation programme in the UK

The Lancet infectious diseases, 2021-04, Vol.21 (4), p.e93-e102 [Peer Reviewed Journal]

2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30492-8 ;PMID: 33129426

Full text available

10
Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004–11: an observational study
Material Type:
Article
Add to My Research

Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004–11: an observational study

The Lancet infectious diseases, 2014-04, Vol.14 (4), p.301-307 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 2014 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(13)70332-3 ;PMID: 24508198 ;CODEN: LANCAO

Full text available

11
Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March-June 2021, England
Material Type:
Article
Add to My Research

Real-world data shows increased reactogenicity in adults after heterologous compared to homologous prime-boost COVID-19 vaccination, March-June 2021, England

Euro surveillance : bulletin européen sur les maladies transmissibles, 2021-07, Vol.26 (28), p.1 [Peer Reviewed Journal]

Copyright Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS) Jul 15, 2021 ;This article is copyright of the authors or their affiliated institutions, 2021. 2021 The authors or their affiliated institutions ;ISSN: 1560-7917 ;ISSN: 1025-496X ;EISSN: 1560-7917 ;DOI: 10.2807/1560-7917.es.2021.26.28.2100634 ;PMID: 34269172

Full text available

12
Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement
Material Type:
Article
Add to My Research

Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement

The Lancet infectious diseases, 2014-04, Vol.14 (4), p.341-352 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 2014 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(13)70324-4 ;PMID: 24631223 ;CODEN: LANCAO

Full text available

13
Secondary attack rates in primary and secondary school bubbles following a confirmed case: Active, prospective national surveillance, November to December 2020, England
Material Type:
Article
Add to My Research

Secondary attack rates in primary and secondary school bubbles following a confirmed case: Active, prospective national surveillance, November to December 2020, England

PloS one, 2022-02, Vol.17 (2), p.e0262515-e0262515 [Peer Reviewed Journal]

COPYRIGHT 2022 Public Library of Science ;2022 Powell et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 Powell et al 2022 Powell et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0262515 ;PMID: 35171942

Full text available

14
Feasibility and acceptability of SARS-CoV-2 testing and surveillance in primary school children in England: Prospective, cross-sectional study
Material Type:
Article
Add to My Research

Feasibility and acceptability of SARS-CoV-2 testing and surveillance in primary school children in England: Prospective, cross-sectional study

PloS one, 2021-08, Vol.16 (8), p.e0255517-e0255517 [Peer Reviewed Journal]

COPYRIGHT 2021 Public Library of Science ;2021 Aiano et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Aiano et al 2021 Aiano et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0255517 ;PMID: 34449784

Full text available

15
Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, England
Material Type:
Article
Add to My Research

Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, England

Emerging infectious diseases, 2021-09, Vol.27 (9), p.2495-2497 [Peer Reviewed Journal]

COPYRIGHT 2021 U.S. National Center for Infectious Diseases ;Published 2021. This article is a U.S. Government work and is in the public domain in the USA. ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2709.204866 ;PMID: 34193335

Full text available

16
Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007–08 and 2014–15: a qualitative and quantitative assessment
Material Type:
Article
Add to My Research

Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007–08 and 2014–15: a qualitative and quantitative assessment

The Lancet infectious diseases, 2017-07, Vol.17 (7), p.754-762 [Peer Reviewed Journal]

Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 1, 2017 ;2017. Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(17)30170-6 ;PMID: 28366725

Full text available

17
Timing of meningococcal vaccination with 4CMenB (Bexsero®) in children with invasive meningococcal group B (MenB) disease in England
Material Type:
Article
Add to My Research

Timing of meningococcal vaccination with 4CMenB (Bexsero®) in children with invasive meningococcal group B (MenB) disease in England

Vaccine, 2022-03, Vol.40 (10), p.1493-1498 [Peer Reviewed Journal]

2021 ;Crown Copyright © 2021. Published by Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 1, 2022 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2021.12.010 ;PMID: 35148913

Full text available

18
Hepatitis E outbreak on cruise ship
Material Type:
Article
Add to My Research

Hepatitis E outbreak on cruise ship

Emerging infectious diseases, 2009-11, Vol.15 (11), p.1738-1744 [Peer Reviewed Journal]

COPYRIGHT 2009 U.S. National Center for Infectious Diseases ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid1511.091094 ;PMID: 19891860

Full text available

19
Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara–Bavaria Nordic vaccine against mpox in children: a national outbreak response
Material Type:
Article
Add to My Research

Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara–Bavaria Nordic vaccine against mpox in children: a national outbreak response

The Lancet infectious diseases, 2023-09, Vol.23 (9), p.1042-1050 [Peer Reviewed Journal]

2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2023. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(23)00270-0 ;PMID: 37336224

Full text available

20
Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010–2015
Material Type:
Article
Add to My Research

Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010–2015

Vaccine, 2018-06, Vol.36 (26), p.3876-3881 [Peer Reviewed Journal]

2018 ;Copyright © 2018. Published by Elsevier Ltd. ;Copyright Elsevier Limited Jun 18, 2018 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2018.02.038 ;PMID: 29699791

Full text available

Results 1 - 20 of 92  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (91)

Refine My Results

Creation Date 

From To
  1. Before 2003  (4)
  2. 2003 To 2008  (7)
  3. 2009 To 2012  (4)
  4. 2013 To 2017  (19)
  5. After 2017  (59)
  6. More options open sub menu

Searching Remote Databases, Please Wait